Compare $CARL vs $OBIO | Chartloom

Compare

$CARL vs $OBIO

Carlsmed Inc · Orchestra Biomed Holdings Inc

CARL

Carlsmed Inc

OBIO

Orchestra Biomed Holdings Inc

Compare $CARL vs $OBIO

Comparing Carlsmed Inc and Orchestra Biomed Holdings Inc

CARLCarlsmed Inc

OBIOOrchestra Biomed Holdings Inc

CARLCarlsmed Inc

Market cap

$392M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.18x

Rev growth (TTM)

16.1%

YTD performance

24.0%

52W performance

4.3%

FCF yield

-9.1%

OBIOOrchestra Biomed Holdings Inc

Market cap

$356M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

789.20x

Rev growth (TTM)

986.1%

YTD performance

38.1%

52W performance

105.2%

FCF yield

-16.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CARL

OBIO

Detailed metrics comparison

CARL

Carlsmed Inc

OBIO

Orchestra Biomed Holdings Inc

Market Cap

CARL$392M

OBIO$356M

Enterprise Value

CARL$361M

OBIO$371M

Price

CARL$14.42

OBIO$5.95

P/E Ratio

CARLN/A

OBION/A

P/S Ratio

CARL6.19x

OBIO11.14x

EV/Sales

CARL5.70x

OBIO11.59x

EV/EBITDA

CARL0.00x

OBIO0.00x

P/B Ratio

CARL4.62x

OBIO12.16x

P/FCF Ratio

CARLN/A

OBION/A

EV/FCF

CARL-10.12x

OBIO-6.27x

PEG Ratio

CARLN/A

OBION/A

Forward P/E (NTM)

CARLN/A

OBION/A

Forward P/S (NTM)

CARL4.18x

OBIO789.20x

Revenue (TTM)

CARL$63M

OBIO$32M

Revenue Growth (YoY)

CARL16.1%

OBIO986.1%

Forward Rev Growth

CARL40.9%

OBIO51.2%

Gross Margin (TTM)

CARL76.6%

OBIO99.5%

Operating Margin (TTM)

CARL0.0%

OBIO0.0%

EBITDA Margin (TTM)

CARL-60.4%

OBIO-180.3%

Net Margin (TTM)

CARL-57.4%

OBIO-186.3%

FCF Margin (TTM)

CARL-56.4%

OBIO-184.8%

Net Income (TTM)

CARL$-36M

OBIO$-60M

FCF (TTM)

CARL$-36M

OBIO$-59M

EPS (TTM)

CARL-$1.34

OBIO-$0.93

ROE (TTM)

CARL-3806.0%

OBIO-12578.0%

ROA (TTM)

CARL-2896.0%

OBIO-5409.0%

ROIC (TTM)

CARL-3278.0%

OBIO-8895.0%

Cash

CARL$46M

OBIO$20M

Debt

CARL$15M

OBIO$35M

Net Cash/Debt

CARL$31M

OBIO$-14M

Current Ratio (TTM)

CARL8.84x

OBIO8.26x

Quick Ratio (TTM)

CARL8.32x

OBIO8.17x

Debt/Equity (TTM)

CARL0.18x

OBIO1.18x

Debt/Assets (TTM)

CARL0.0%

OBIO0.0%

Interest Coverage (TTM)

CARLN/A

OBION/A

Net Debt/EBITDA (TTM)

CARL0.00x

OBIO0.00x

Beta

CARL2.13

OBIO0.55

52W Performance

CARL4.3%

OBIO105.2%

YTD Performance

CARL24.0%

OBIO38.1%

% from 52W High

CARL-16.3%

OBIO-8.5%

% from 52W Low

CARL69.6%

OBIO114.1%

Asset Turnover (TTM)

CARL0.50x

OBIO0.29x

FCF Yield (TTM)

CARL-9.1%

OBIO-16.6%

Earnings Yield (TTM)

CARL-9.3%

OBIO-16.7%

Dividend Yield (TTM)

CARLN/A

OBION/A

Rule of 40

CARL-40.3

OBIO801.3

EV/GP/RG

CARL0.14

OBIO0.17

Ticker research

View CARL research View OBIO research

Metric	CARL Carlsmed Inc	OBIO Orchestra Biomed Holdings Inc
Market & Valuation
Market Cap	$392M	$356M
Enterprise Value	$361M	$371M
Price	$14.42	$5.95
P/E Ratio	N/A	N/A
P/S Ratio	6.19x	11.14x
EV/Sales	5.70x	11.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.62x	12.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.12x	-6.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	789.20x
Revenue & Growth
Revenue (TTM)	$63M	$32M
Revenue Growth (YoY)	16.1%	986.1%
Forward Rev Growth	40.9%	51.2%
Profitability
Gross Margin (TTM)	76.6%	99.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-60.4%	-180.3%
Net Margin (TTM)	-57.4%	-186.3%
FCF Margin (TTM)	-56.4%	-184.8%
Net Income (TTM)	$-36M	$-60M
FCF (TTM)	$-36M	$-59M
EPS (TTM)	-$1.34	-$0.93
ROE (TTM)	-3806.0%	-12578.0%
ROA (TTM)	-2896.0%	-5409.0%
ROIC (TTM)	-3278.0%	-8895.0%
Financial Health
Cash	$46M	$20M
Debt	$15M	$35M
Net Cash/Debt	$31M	$-14M
Current Ratio (TTM)	8.84x	8.26x
Quick Ratio (TTM)	8.32x	8.17x
Debt/Equity (TTM)	0.18x	1.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.13	0.55
52W Performance	4.3%	105.2%
YTD Performance	24.0%	38.1%
% from 52W High	-16.3%	-8.5%
% from 52W Low	69.6%	114.1%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.29x
FCF Yield (TTM)	-9.1%	-16.6%
Earnings Yield (TTM)	-9.3%	-16.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-40.3	801.3
EV/GP/RG	0.14	0.17
Ticker research	View CARL research	View OBIO research

Valuation

P/S Ratio

CARL

6.19x

OBIO

11.14x

EV/FCF

CARL

-10.12x

OBIO

-6.27x

Growth & revenue

Revenue Growth TTM

OBIO

986.1%

CARL

16.1%

Forward Revenue Growth

OBIO

51.2%

CARL

40.9%

Profitability & performance

Gross Margin

OBIO

99.5%

CARL

76.6%

ROE

CARL

-3806.0%

OBIO

-12578.0%

FCF Yield %

CARL

-9.1%

OBIO

-16.6%

52-Week Performance

OBIO

105.2%

CARL

4.3%

Detailed metrics comparison

CARL

Carlsmed Inc

OBIO

Orchestra Biomed Holdings Inc

Market Cap

CARL$392M

OBIO$356M

Enterprise Value

CARL$361M

OBIO$371M

Price

CARL$14.42

OBIO$5.95

P/E Ratio

CARLN/A

OBION/A

P/S Ratio

CARL6.19x

OBIO11.14x

EV/Sales

CARL5.70x

OBIO11.59x

EV/EBITDA

CARL0.00x

OBIO0.00x

P/B Ratio

CARL4.62x

OBIO12.16x

P/FCF Ratio

CARLN/A

OBION/A

EV/FCF

CARL-10.12x

OBIO-6.27x

PEG Ratio

CARLN/A

OBION/A

Forward P/E (NTM)

CARLN/A

OBION/A

Forward P/S (NTM)

CARL4.18x

OBIO789.20x

Revenue (TTM)

CARL$63M

OBIO$32M

Revenue Growth (YoY)

CARL16.1%

OBIO986.1%

Forward Rev Growth

CARL40.9%

OBIO51.2%

Gross Margin (TTM)

CARL76.6%

OBIO99.5%

Operating Margin (TTM)

CARL0.0%

OBIO0.0%

EBITDA Margin (TTM)

CARL-60.4%

OBIO-180.3%

Net Margin (TTM)

CARL-57.4%

OBIO-186.3%

FCF Margin (TTM)

CARL-56.4%

OBIO-184.8%

Net Income (TTM)

CARL$-36M

OBIO$-60M

FCF (TTM)

CARL$-36M

OBIO$-59M

EPS (TTM)

CARL-$1.34

OBIO-$0.93

ROE (TTM)

CARL-3806.0%

OBIO-12578.0%

ROA (TTM)

CARL-2896.0%

OBIO-5409.0%

ROIC (TTM)

CARL-3278.0%

OBIO-8895.0%

Cash

CARL$46M

OBIO$20M

Debt

CARL$15M

OBIO$35M

Net Cash/Debt

CARL$31M

OBIO$-14M

Current Ratio (TTM)

CARL8.84x

OBIO8.26x

Quick Ratio (TTM)

CARL8.32x

OBIO8.17x

Debt/Equity (TTM)

CARL0.18x

OBIO1.18x

Debt/Assets (TTM)

CARL0.0%

OBIO0.0%

Interest Coverage (TTM)

CARLN/A

OBION/A

Net Debt/EBITDA (TTM)

CARL0.00x

OBIO0.00x

Beta

CARL2.13

OBIO0.55

52W Performance

CARL4.3%

OBIO105.2%

YTD Performance

CARL24.0%

OBIO38.1%

% from 52W High

CARL-16.3%

OBIO-8.5%

% from 52W Low

CARL69.6%

OBIO114.1%

Asset Turnover (TTM)

CARL0.50x

OBIO0.29x

FCF Yield (TTM)

CARL-9.1%

OBIO-16.6%

Earnings Yield (TTM)

CARL-9.3%

OBIO-16.7%

Dividend Yield (TTM)

CARLN/A

OBION/A

Rule of 40

CARL-40.3

OBIO801.3

EV/GP/RG

CARL0.14

OBIO0.17

Ticker research

View CARL research View OBIO research

Metric	CARL Carlsmed Inc	OBIO Orchestra Biomed Holdings Inc
Market & Valuation
Market Cap	$392M	$356M
Enterprise Value	$361M	$371M
Price	$14.42	$5.95
P/E Ratio	N/A	N/A
P/S Ratio	6.19x	11.14x
EV/Sales	5.70x	11.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.62x	12.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.12x	-6.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	789.20x
Revenue & Growth
Revenue (TTM)	$63M	$32M
Revenue Growth (YoY)	16.1%	986.1%
Forward Rev Growth	40.9%	51.2%
Profitability
Gross Margin (TTM)	76.6%	99.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-60.4%	-180.3%
Net Margin (TTM)	-57.4%	-186.3%
FCF Margin (TTM)	-56.4%	-184.8%
Net Income (TTM)	$-36M	$-60M
FCF (TTM)	$-36M	$-59M
EPS (TTM)	-$1.34	-$0.93
ROE (TTM)	-3806.0%	-12578.0%
ROA (TTM)	-2896.0%	-5409.0%
ROIC (TTM)	-3278.0%	-8895.0%
Financial Health
Cash	$46M	$20M
Debt	$15M	$35M
Net Cash/Debt	$31M	$-14M
Current Ratio (TTM)	8.84x	8.26x
Quick Ratio (TTM)	8.32x	8.17x
Debt/Equity (TTM)	0.18x	1.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.13	0.55
52W Performance	4.3%	105.2%
YTD Performance	24.0%	38.1%
% from 52W High	-16.3%	-8.5%
% from 52W Low	69.6%	114.1%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.29x
FCF Yield (TTM)	-9.1%	-16.6%
Earnings Yield (TTM)	-9.3%	-16.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-40.3	801.3
EV/GP/RG	0.14	0.17
Ticker research	View CARL research	View OBIO research